Previous Article | Next Article ![]()
Infection and Immunity, February 2003, p. 717-725, Vol. 71, No. 2
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.2.717-725.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Oral Microbiology, Asahi University School of Dentistry, 1851-1 Hozumi, Motosu-gun, Gifu 501-0296, Japan
Received 25 July 2002/ Returned for modification 29 August 2002/ Accepted 3 November 2002
| ABSTRACT |
|---|
|
|
|---|
B activation in HGEC. Among them, T. denticola especially exhibited trypsin- and chymotrypsin-like protease activities, and the addition of chymostatin, a chymotrypsin protease inhibitor, resulted in detectable IL-8 production by HGEC cultured with T. denticola. Additionally, IL-8 mRNA expression in HGEC cultured with the three treponemes and their OMEs was definitely inhibited by the mouse anti-human Toll-like receptor 2 (TLR2) monoclonal antibody TL2.1. These findings suggest that oral treponemes and their OMEs activate HGEC through TLR2. | INTRODUCTION |
|---|
|
|
|---|
Various cytokines have been shown to play important roles in the pathogenesis of periodontal diseases (43, 58). Among them, interleukin 8 (IL-8), a CXC chemokine produced by gingival epithelial cells, is considered to be an important factor that initiates inflammatory reactions in gingival tissues (24). IL-8 has been detected in the gingival tissues of patients with periodontal diseases, and the level of IL-8 mRNA has also been demonstrated to correspond to the severity of periodontal diseases (53).
Human gingival epithelial cells (HGEC) play an important role as the first barrier against periodontopathic bacteria and their metabolic products (25). Asai et al. previously established immortalized epithelial cell lines, derived from human gingival tissues, in order to study their interactions with periodontopathic bacteria (4). The Toll-like receptor (TLR) family, a large family with extracellular leucine-rich repeats and a cytoplasmic Toll-IL-1 receptor homology domain and for which 10 members (TLR1 to TLR10) have been reported, is known to play an important role in the recognition of structurally conserved pathogen-associated microbial products (4, 11, 12, 17, 36, 37, 44, 50, 57). In the present study, we attempted to demonstrate the profiles of expression of all of the known TLRs and their related molecules from HGEC as well as the mechanisms of recognition and activation of these cells with the oral treponemes T. denticola, T. vincentii, and T. medium and their outer membrane extracts (OMEs).
| MATERIALS AND METHODS |
|---|
|
|
|---|
The oral treponeme OMEs were prepared as described previously (28). Briefly, the bacterial cells were harvested during the late stationary phase, washed, resuspended in PBS containing 10 mM MgCl2, and extracted in Triton X-100. After repeated centrifugation, the supernatant was dialyzed for several days until the outer membrane was precipitated, and then centrifugation at 25,000 x g was performed. The pellet was resuspended in distilled water and stored at -20°C until use. The dry weight of the extract was determined after freeze-drying. For all experiments, the OMEs were dissolved in PBS and serially diluted with pyrogen-free cell culture medium. Endotoxicity could not be detected in these preparations by a colorimetric Limulus amoebocyte lysate assay (Seikagaku Co., Tokyo, Japan).
Reagents. Mouse anti-human TLR2 monoclonal antibody TL2.1 was purchased from Cascade Bioscience Inc. (Winchester, Miss.). Mouse immunoglobulin G2a (IgG2a; Dako, Glostrup, Denmark) was used as an isotype control for TL2.1. Phorbol 12-myristate 13-acetate (PMA) was obtained from Sigma. Chymostatin (Roche, Indianapolis, Ind.) was dissolved at 1.5 mg/ml in dimethyl sulfoxide and then serially diluted with pyrogen-free cell culture medium as described below.
Cells. The generation of the human papillomavirus 16 E6- and E7-immortalized HGEC lines HGEC-1 and HGEC-2 has been described elsewhere (4). Other cell lines, HGEC-3 and HGEC-4, from normal human gingival tissues (ca. 500 mg) obtained from two patients who required tooth extraction for reasons other than periodontal disease after receiving informed consent, were also established. These cell lines were subsequently maintained in a long-term culture with HuMedia-KG2 (Kurabo Biomedicals, Osaka, Japan) and used between passages 50 and 60. Human intestinal epithelial cell line Caco-2 was obtained from Dainippon Pharmaceutical (Osaka, Japan) and maintained in Eagle's minimum essential medium (Sigma) supplemented with 10% fetal bovine serum (Sigma) and 0.1 mM nonessential amino acids (Gibco). Heparinized venous blood was drawn from healthy donors and subjected to fractionation with Histopaque-1077 (Sigma) to obtain human peripheral blood mononuclear cells (PBMC) (6).
RT-PCR. Total cellular RNAs were extracted from HGEC and PBMC with RNAzolB (Tel-Test, Friendswood, Tex.) according to the manufacturer's instructions and then treated with RNase-free DNase (Takara Biochemicals, Shiga, Japan) as described previously (16). Reverse transcription (RT) and PCR were conducted by using avian myeloblastosis virus reverse transcriptase (TaKaRa Biochemicals) and Taq polymerase (TaKaRa), respectively. PCR assays were conducted for 30 cycles with a TaKaRa Thermal Cycler MP by using the primer pairs and conditions described in Table 1. For the detection of IL-8 and IL-6 mRNAs in HGEC-1, total cellular RNAs were extracted after HGEC-1 were cultured with 5 x 107 cells of the oral treponemes or 1 µg of OMEs/ml for 2 h. In some experiments, HGEC-1 were incubated with or without 1 µg of TL2.1 or mouse IgG2a/ml for 30 min at room temperature before the addition of the oral treponemes or their OMEs. As a negative control, non-reverse-transcribed samples were amplified by PCR. Following PCR, 10 µl of the total amplified product was electrophoresed on ethidium bromide-stained 1% agarose gels and visualized under UV fluorescence.
|
B-Luc (Stratagene Co., La Jolla, Calif.) by using TransFast transfection reagent (Promega Co., Madison, Wis.). Plasmid pFC-MEKK was used as a positive control plasmid in this assay. After an initial incubation for 24 h, HGEC were incubated with 5 x 107 cells of the oral treponemes in 500 µl of HuMedia-KG2 at 37°C for 4 h. After incubation, luciferase activity was determined by using a luciferase assay substrate (Promega), and luminescence was quantified with a Luminometer (Promega). Detection of IL-8 production. A single cell suspension (105 cells per well) was seeded in a 24-well flat-bottom microtiter plate. After incubation for 16 h at 37°C in humidified air containing 5% (vol/vol) CO2, the monolayers were washed three times with PBS. The cells were incubated with various doses of the oral treponemes and their OMEs for various times at 37°C in humidified air containing 5% (vol/vol) CO2; the mixtures then were centrifuged at 12,000 x g for 5 min. In some experiments, HGEC were incubated with or without 1 µg of TL2.1 or mouse IgG2a/ml for 30 min at room temperature before the addition of the test specimens. The supernatants were stored at -80°C until assayed for cytokine production. The production of IL-8 in the culture supernatants was determined by an enzyme-linked immunosorbent assay (ELISA) performed according to the manufacturer's instructions (ELISA kit system; Genzyme-Techne, Minneapolis, Minn.), and the results were analyzed by using a standard curve prepared for each assay.
Analysis of enzymatic activity. The amounts of cell-associated enzymes in the oral treponemes were determined from cells grown in TYGVS broth as described above. These cells were centrifuged and then suspended in PBS for enzyme analysis. An API ZYM chromogenic assay system (Biomerieux, Marcy-l'Etoile, France) was used for the estimation of enzyme levels, and the intensity of the color reaction was graded semiquantitatively by comparison to a standard API ZYM color reaction chart. Three independent experiments with the different treponemes were performed.
PMA-induced IL-8 degradation. HGEC were incubated with 10 ng of PMA/ml for 24 h at 37°C in humidified air containing 5% (vol/vol) CO2, and supernatants were collected by centrifugation at 12,000 x g for 5 min. The oral treponemes at various doses were cultured in the same supernatant (1 ml/well) under the same culture conditions. After incubation, IL-8 levels in the supernatants were measured by an ELISA.
Effect of chymostatin on IL-8 degradation. HGEC were seeded in a 24-well plate in a manner similar to that described above. The oral treponemes were washed three times with or without 30 µg of chymostatin/ml in PBS and then suspended at a density of 107 cells/ml in HuMedia-KG2 with or without 30 µg of chymostatin/ml. HGEC were cultured with 107 cells of the oral treponemes treated or not treated with chymostatin at 37°C for 12 h. After incubation, supernatants were collected, and IL-8 production was measured by an ELISA.
Statistics. Data were analyzed by a one-way analysis of variance (ANOVA) with the Bonferroni or Dunn method, and the results are presented as the means ± standard errors of the means (SEM). When an individual result is presented, it is representative of at least three independent experiments.
| RESULTS |
|---|
|
|
|---|
B activation in HGEC cultured with oral treponemes were examined. T. denticola, T. vincentii, and T. medium each clearly induced IL-8 and IL-6 mRNA expression in HGEC (Fig. 1A). These oral treponemes also clearly induced NF-
B activation in a cell-dependent manner (Fig. 1B). Further, we examined IL-8 production by HGEC cultured with various doses of T. denticola, T. vincentii, and T. medium. T. medium and T. vincentii induced significant IL-8 production by HGEC-1 in time- and cell-dependent manners, whereas IL-8 was scarcely found after culturing with T. denticola (Fig. 2). HGEC-2, HGEC-3, and HGEC-4, similar to HGEC-1, were shown to have induced IL-8 and IL-6 mRNA expression and IL-8 production (data not shown).
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Asai et al. previously found that immortalized gingival epithelial cell lines, HGEC-1 and HGEC-2, expressed TLR2 but not CD14 or TLR4 on the cell surfaces and also responded to S. aureus peptidoglycan and muramyl dipeptide, a common component of cell wall peptidoglycan, as TLR2 ligands but not to Escherichia coli-type synthetic lipid A as a TLR4 ligand (4). Porphyromonas gingivalis lipopolysaccharide (LPS) and its lipid A fraction were recognized as utilizing TLR2 (33). Ogawa et al. recently showed that further purified P. gingivalis lipid A and its synthetic counterpart induced cell activation via a TLR4/MD-2-MyD88-dependent pathway and that minor bacterial components separated from P. gingivalis lipid A fractions activated cells utilizing TLR2 (36). HGEC did not respond to further purified P. gingivalis 381 lipid A and its synthetic compound (compound PG-381), which is similar to the results obtained for compound 506 (unpublished observations).
It was also shown that epithelial cells from normal human vagina, ectocervix, and endocervix tissues expressed mRNAs for TLR1, TLR2, TLR3, TLR5, and TLR6. However, mRNA for TLR4, which plays an important role as a receptor for bacterial LPS and its active center, lipid A, and mRNA for MD-2, a small secreted protein associated with TLR4 on the surface of innate immune cells, were not expressed (18, 23, 40, 48). A TLR-related protein, RP105, has been identified in B cells and shown to act as both an LPS sensor and a regulator of B-cell proliferation (35). RP105, like TLR4, also requires an MD-2-related protein, MD-1, for its surface expression (32). Further, TLR2 is essential for the signaling of various bacterial components, such as Staphylococcus aureus peptidoglycan (49) and its bioactive muramyl dipeptide (4), bacterial lipoprotein (2, 7), lipoteichoic acid (29), zymosan (56), and P. gingivalis fimbriae (4, 37). In addition, TLR3, TLR5, TLR7, and TLR9 are known to recognize double-stranded viral RNA, bacterial flagellin, imidazoquinoline compound imiquimod and R-848, and bacterial CpG DNA, respectively (1, 20-22). In the present study, the expression of mRNAs for the known TLRs, RP105, and several other proteins in HGEC was examined, and the cells failed to express mRNAs for TLR4, RP105, MD-1, MD-2, or CD14 (Fig. 5) (4). These results indicate that HGEC-1 lack known whole molecules for the recognition and activation of bacterial LPS and its active center, lipid A.
In the present study, we observed IL-8 production in HGEC cultured with T. vincentii and T. medium but not with T. denticola (Fig. 2). It was previously shown that KB cells, a human oral epithelial cell line, cultured with T. denticola expressed no IL-8 production (14). On the other hand, T. denticola, T. vincentii, and T. medium each clearly induced IL-8 mRNA expression as well as NF-
B activation in HGEC in the present study (Fig. 1). Further, the OMEs from these oral treponemes also induced IL-8 production in HGEC (Fig. 7A).
In previous studies, P. gingivalis exhibited a high level of protease activity, after which the protease seemed to reduce IL-8 production by gingival epithelial cells (59), while T. denticola showed highly proteolytic activities (19, 26) and its chymotrypsin-like proteases induced cytopathic activities, such as loosening of cell contacts, collapse of intercellular spaces, and an increase in the permeability of epithelial cells (54). Further, stimulation of a dentilisin protease mutant of T. denticola resulted in an increase in IL-8 production in KB cells (14). In the present study, T. denticola exhibited a variety of protease activities, compared with T. vincentii and T. medium (Table 2); these activities resulted in a decrease in IL-8 production in HGEC induced by PMA (Fig. 3). Further, the increase in IL-8 production induced in HGEC by T. denticola was also seen with additional chymostatin (Fig. 4). These results suggest that a chymotrypsin-like protease from T. denticola degrades exogenous IL-8 production induced by HGEC, an activity which may play an important role in the defense against host immune defenses.
In the present study, we examined the activation of HGEC against three oral treponemes. TLR2 has been shown to be a signal transducer of lipoprotein and lipopeptide from Treponema pallidum, which is associated with syphilis (30). Further, it has also been shown that the glycolipid from Treponema maltophilum, associated with periodontitis in humans, and that of Treponema brennaborense, found in bovine cattle, induce NF-
B activation through TLR2 (38). In our study, a mouse anti-human TLR2 monoclonal antibody, TL2.1, clearly inhibited IL-8 mRNA expression and IL-8 production in HGEC cultured with the three oral treponemes and their OMEs (Fig. 6 and 7B). Human intestinal epithelial cell lines Caco-2 and T84 also have been demonstrated to express TLR2 (8); the OMEs induced IL-8-producing activities in Caco-2 cells (Fig. 7A). These findings suggested that oral treponemes and their OMEs activated other types of epithelial cells expressing TLR2. TLR1 and TLR6 have been shown to associate with TLR2 and to recognize mycoplasmal lipopeptide and mycobacterial lipoprotein along with TLR2, respectively (51, 52). As HGEC expressed mRNAs for TLR1 and TLR6 (Fig. 1), TLR1 and TLR6 may be associated with the recognition of oral treponemes and their OMEs by TLR2. Taken together, the results show that the oral treponemes activate HGEC through TLR2, followed by the induction of NF-
B activation, IL-8 mRNA expression, and IL-8 production. T. denticola, which was distinct from T. vincentii and T. medium in the present study, possesses highly proteolytic activities, which produce enzymes that degrade the exogenous IL-8 produced by HGEC.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.[CrossRef][Medline] |
| 2. | Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739. |
| 3. | Asai, Y., T. Jinno, H. Igarashi, Y. Ohyama, and T. Ogawa. 2002. Detection and quantification of oral treponemes in subgingival plaque by real-time PCR. J. Clin. Microbiol. 40:3334-3340. |
| 4. | Asai, Y., Y. Ohyama, K. Gen, and T. Ogawa. 2001. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect. Immun. 69:7387-7395. |
| 5. | Bartold, P. M., L. J. Walsh, and A. S. Narayanan. 2000. Molecular and cell biology of the gingiva. Periodontology 24:28-55. |
| 6. | Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Investig. 97:77-89. |
| 7. | Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736. |
| 8. | Cario, E., I. M. Rosenberg, S. L. Brandwein, P. L. Beck, H.-C. Reinecker, and D. K. Podolsky. 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164:966-972. |
| 9. | Carranza, N., G. R. Riviere, K. S. Smith, D. F. Adams, and T. Maier. 1997. Differential attachment of oral treponemes to monolayers of epithelial cells. J. Periodontol. 68:1010-1018.[Medline] |
| 10. | Chan, E. C., and R. McLaughlin. 2000. Taxonomy and virulence of oral spirochetes. Oral Microbiol. Immunol. 15:1-9.[CrossRef][Medline] |
| 11. | Chuang, T. H., and R. J. Ulevitch. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518:157-161.[Medline] |
| 12. | Chuang, T. H., and R. J. Ulevitch. 2000. Cloning and characterization of a subfamily of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11:372-378.[Medline] |
| 13. | Courtois, G. J., III, C. M. Cobb, and W. J. Killoy. 1983. Acute necrotizing ulcerative gingivitis. A transmission electron microscope study. J. Periodontol. 54:671-679.[Medline] |
| 14. | Deng, Q. D., Y. Han, X. Xia, and H. K. Kuramitsu. 2001. Effects of the oral spirochete Treponema denticola on interleukin-8 expression from epithelial cells. Oral Microbiol. Immunol. 16:185-187.[CrossRef][Medline] |
| 15. | Dewhirst, F. E., M. A. Ericson, C. N. Lau, V. A. Levanos, S. K. Boches, J. L. Galvin, and B. J. Paster. 2000. The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol. Immunol. 15:196-202.[CrossRef][Medline] |
| 16. | Dilworth, D., and J. R. McCarrey. 1992. Single-step elimination of contaminating DNA prior to reverse transcriptase PCR. PCR Methods Appl. 1:279-282.[Medline] |
| 17. | Du, X., Y. Poltrak, Y. Wei, and B. Beutler. 2000. Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11:362-371.[Medline] |
| 18. | Fichorova, R. N., A. O. Cronin, E. Lien, D. J. Anderson, and R. R. Ingalls. 2002. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J. Immunol. 168:2424-2432. |
| 19. | Grenier, D., V. J. Uitto, and B. C. McBridge. 1990. Cellular location of a Treponemea denticola chymotrypsinlike protease and importance of the protease in migration through the basement membrane. Infect. Immun. 58:347-351. |
| 20. | Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103.[CrossRef][Medline] |
| 21. | Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.[CrossRef][Medline] |
| 22. | Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196-200.[CrossRef][Medline] |
| 23. | Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752. |
| 24. | Huang, G. T.-J., S. K. Haake, J.-W. Kim, and N.-H. Park. 1998. Differential expression of interleukin-8 and intercellular adhesion molecule-1 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans or Porphyromonas gingivalis infection. Oral Microbiol. Immunol. 13:301-309.[Medline] |
| 25. | Kagnoff, M. F., and L. Eckmann. 1997. Epithelial cells as sensors for microbial infection. J. Clin. Investig. 100:6-10.[Medline] |
| 26. | Kesavalu, L., S. G. Walker, S. C. Holt, R. R. Crawley, and J. L. Ebersole. 1997. Virulence characteristics of oral treponemes in a murine model. Infect. Immun. 65:5096-5102.[Abstract] |
| 27. | Keulers, R. A., J. C. Maltha, F. H. Mikx, and J. M. Wolters-Lutgerhorst. 1993. Attachment of T. denticola strains ATCC 33520, ATCC 35405, B11 and Ny541 to a morphologically distinct population of rat palatal epithelial cells. J. Periodontal Res. 28:274-280.[CrossRef][Medline] |
| 28. | Ko, K. S., M. Glogauer, C. A. McCulloch, and R. P. Ellen. 1998. Treponema denticola outer membrane inhibits calcium flux in gingival fibroblasts. Infect. Immun. 66:703-709. |
| 29. | Lehner, M. D., S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166:5161-5167. |
| 30. | Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-33425. |
| 31. | Loesche, W. J. 1998. The role of spirochetes in periodontal disease. Adv. Dent. Res. 2:275-283. |
| 32. | Miyake, K., H. Ogata, Y. Nagai, S. Akashi, and M. Kimoto. 2000. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J. Endotoxin Res. 6:389-391.[CrossRef] |
| 33. | Netea, M. G., M. van Deuren, B. J. Kullberg, J. M. Cavaillon, and J. W. van der Meer. 2002. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol. 23:135-139.[CrossRef][Medline] |
| 34. | Nixon, C. S., M. J. Steffen, and J. L. Ebersole. 2000. Cytokine responses to Treponema pectinovorum and Treponema denticola in human gingival fibroblasts. Infect. Immun. 68:5284-5292. |
| 35. | Ogata, H., I. Su, K. Miyake, Y. Nagai, S. Akashi, I. Mecklenbrauker, K. Rajewsky, M. Kimoto, and A. Tarakhovsky. 2000. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192:23-29. |
| 36. | Ogawa, T., Y. Asai, M. Hashimoto, O. Takeuchi, T. Kurita, Y. Yoshikai, K. Miyake, and S. Akira. 2002. Cell activation by Porphyromonas gingivalis lipid A molecule through TLR4- and MyD88-dependent signaling pathway. Int. Immunol. 14:1-8. |
| 37. | Ogawa, T., Y. Asai, M. Hashimoto, and H. Uchida. 2002. Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors. Eur. J. Immunol. 32:2543-2550.[CrossRef][Medline] |
| 38. | Opitz, B., N. W. Schroder, I. Spreitzer, K. S. Michelsen, C. J. Kirschning, W. Hallatschek, U. Zahringer, T. Hartung, U. B. Gobel, and R. R. Schumann. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J. Biol. Chem. 276:22041-22047. |
| 39. | Peters, S. R., M. Valdez, G. Riviere, and D. D. Thomas. 1999. Adherence to and penetration through endothelial cells by oral treponemes. Oral Microbiol. Immunol. 14:379-383.[CrossRef][Medline] |
| 40. | Poltorak, A., X. He, I. Smirnova, M.-Y., Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088. |
| 41. | Rams, T. E., M. Andriolo, D. Feik, S. N. Abel, T. M. McGivern, and J. Slots. 1991. Microbiological study of HIV-related periodontitis. J. Periodontol. 62:74-81.[Medline] |
| 42. | Riviere, G. R., K. S. Weisz, L. G. Simonson, and S. A. Lukehart. 1991. Pathogen-related spirochetes identified within gingival tissue from patients with acute necrotizing ulcerative gingivitis. Infect. Immun. 59:2653-2657. |
| 43. | Roberts, F. A., K. A. McCaffery, and S. M. Michalek. 1997. Profile of cytokine mRNA expression in chronic adult periodontitis. J. Dent. Res. 76:1833-1839. |
| 44. | Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-593. |
| 45. | Rosenstein, D. I., G. R. Riviere, and K. S. Elott. 1993. HIV-associated periodontal disease: new oral spirochete found. J. Am. Dent. Assoc. 124:76-80.[Abstract] |
| 46. | Ross, K. F., and M. C. Herzberg. 2001. Calprotectin expression by gingival epithelial cells. Infect. Immun. 69:3248-3254. |
| 47. | Schwartz, Z., D. D. Dean, and B. D. Boyan. 1996. The biochemistry and physiology of the periodontium, p. 61-107. In T. G. Wilson and K. S. Kornman (ed.), Fundamentals of periodontics. Quintessence Publishing Co., Inc., Chicago, Ill. |
| 48. | Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782. |
| 49. | Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.[CrossRef][Medline] |
| 50. | Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59-65.[CrossRef][Medline] |
| 51. | Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-940. |
| 52. | Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R. L. Modlin, and S. Akira. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14. |
| 53. | Tonetti, M. S., M. A. Imboden, L. Gerber, N. P. Lang, J. Laissue, and C. Mueller. 1994. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect. Immun. 62:4005-4014. |
| 54. | Uitto, V. J., Y. M. Pan, W. K. Leung, H. Larjava, R. P. Ellen, B. B. Finlay, and B. C. McBride. 1995. Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells. Infect. Immun. 63:3401-3410.[Abstract] |
| 55. | Umemoto, T., T. Jinno, Y. Taiji, and T. Ogawa. 2001. Chemotaxis of oral treponemes toward sera and albumin of rabbit. Microbiol. Immunol. 45:571-577.[Medline] |
| 56. | Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815.[CrossRef][Medline] |
| 57. | Vasselon, T., and P. A. Detmers. 2002. Toll receptors: a central element in innate immune responses. Infect. Immun. 70:1033-1041. |
| 58. | Wilson, M., K. Reddi, and B. Henderson. 1996. Cytokine-inducing components of periodontopathogenic bacteria. J. Periodontal Res. 31:393-407.[CrossRef][Medline] |
| 59. | Zhang, J., H. Dong, S. Kashket, and M. J. Duncan. 1999. IL-8 degradation by Porphyromonas gingivalis proteases. Microb. Pathog. 26:275-280.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|